MedTrace Logo

Families Filming Infants Learning Movement

NCT06278961 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-02-13

No results posted yet for this study

Summary

The study objective is to improve accuracy in the early detection of neurodevelopmental impairment, especially CP, by evaluating the timepoint (in weeks post term age) that the Prechtl GMA is most useful for prediction of neurodevelopmental impairment at two years of age in children with and without medical complexity. The study team plans to recruit 100 healthy, term-born infants and 250 infants at risk of developing CP for a total of 350 enrolled infants.

Conditions

  • Infant Development
  • Cerebral Palsy
  • Motor Disorders
  • Neurological Disorder

Interventions

OTHER

Observational

Observation of movement patterns through video recordings and neurodevelopmental battery of assessments.

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • IRCCS Fondazione Stella Maris

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • University of Sydney

    collaborator OTHER

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Eligibility

Min Age
10 Weeks
Max Age
20 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-28
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06278961 on ClinicalTrials.gov